David A. Siegel Amneal Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 46,449 shares of AMRX stock, worth $475,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,449

Previous 189,049 75.43%

Holding current value

$475,637

Previous $1.58 Million 76.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.97 - $8.23 $993,922 - $1.17 Million	-142,600 Reduced 75.43%	46,449 $375,000
Q1 2025 May 15, 2025	BUY	$7.72 - $9.01 $1.12 Million - $1.31 Million	145,200 Added 331.14%	189,049 $1.58 Million
Q4 2024 Feb 14, 2025	SELL	$7.69 - $9.25 $249,156 - $299,700	-32,400 Reduced 42.49%	43,849 $347,000
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $1.05 Million - $1.44 Million	-163,000 Reduced 68.13%	76,249 $634,000
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $554,224 - $735,174	-103,400 Reduced 30.18%	239,249 $1.52 Million
Q1 2024 May 15, 2024	SELL	$5.24 - $6.34 $505,136 - $611,176	-96,400 Reduced 21.96%	342,649 $2.08 Million
Q4 2023 Feb 14, 2024	SELL	$3.36 - $6.21 $46,032 - $85,077	-13,700 Reduced 3.03%	439,049 $2.67 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $218,867 - $363,987	79,300 Added 21.23%	452,749 $1.91 Million
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $71,687 - $167,090	53,900 Added 16.87%	373,449 $1.16 Million
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $88,011 - $187,110	69,300 Added 27.69%	319,549 $444,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $377,396 - $502,552	192,549 Added 333.71%	250,249 $497,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $243,508 - $436,387	-120,549 Reduced 67.63%	57,700 $117,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $161,035 - $238,610	-53,500 Reduced 23.09%	178,249 $567,000
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $320,580 - $401,958	-82,200 Reduced 26.18%	231,749 $966,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $612,645 - $907,335	155,100 Added 97.64%	313,949 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $451,256 - $590,508	104,700 Added 193.36%	158,849 $848,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $1.1 Million - $1.46 Million	-214,600 Reduced 79.85%	54,149 $277,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $1.27 Million - $1.98 Million	268,749 New	268,749 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $186,633 - $256,089	-47,249 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $672,954 - $1 Million	-190,100 Reduced 80.09%	47,249 $183,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $208,936 - $397,488	-72,800 Reduced 23.47%	237,349 $1.13 Million
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $42,804 - $93,090	17,400 Added 5.94%	310,149 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $58,830 - $123,431	22,200 Added 8.21%	292,749 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $619,557 - $1.92 Million	270,549 New	270,549 $785,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $4.23 Million - $6.26 Million	-257,765 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $3.6 Million - $5.21 Million	257,765 New	257,765 $4.23 Million

Others Institutions Holding AMRX

# of Institutions

250

Shares Held

146M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.55B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account